UNSPSC 85701314: Revision of nonautologous tissue substitute in right pelvic bone, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in right pelvic bone, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QW23KZ

UNSPSC 85701314, Revision of nonautologous tissue substitute in right pelvic bone, percutaneous approach, is a Commodity code that shows minimal alignment with actual state and local procurement activity in the source material. The code describes a specific orthopedic surgical procedure, yet none of the recent opportunities tagged under it involve tissue substitutes, orthopedic implants, or surgical materials procurement. Instead, the opportunities span occupational health surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension boards, surgical procedure networks, and emergency medical services for detained youth—none of which involve procurement or delivery of nonautologous tissue products or related surgical supplies.

The mismatch between the code's clinical procedure scope and the actual opportunities suggests this Commodity code receives limited or mislabeled activity in state and local procurement. No recent solicitations in the source material support vendors or service providers selling tissue substitutes, procurement of implant materials, or related medical device supply under this code. Issuers include Arizona's Phoenix Retirement Office, the City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County, and Santa Clara County Health System—spanning pension administration, employee benefits, occupational health, detention healthcare, and health system staffing. Without concrete recent opportunities properly aligned to tissue substitute procurement or supply, this code presents limited business development signal for firms pursuing state and local contracts in this product category.